Antiinflammatory and Immunosuppressive drugs Flashcards
Physiological properties of Glucocorticoids
Diabetogenic
Gluconeogenesis increases –> Hyperglycaemia
Pathological properties of Glucocorticoids
Muscle atrophy (weakness)
Osteoporosis (decreased calcium absorption)
Delayed wound healing (decreased collagen synthesis)
Skin thinning, alopecia
Decreased growth
Polyuria/polydipsia (ADG inhibition and psychic)
Pharmacological properties of Glucocorticoids
Antiinflammatory Antiallergic Immunosuppressive Antishock Neuroprotective
What does Glucocorticoids inhibit?
It inhibits the production of Phospholipase A2 (PLA2), therefore inhibiting the production of LOX, COX1,2&3, and EOX
Antiinflammatory and Immunosuppressive effects of GC
Decreased COX enzyme expression
Decreased interleukin expression (especially IL1 & 2)
Decreased synthesis of TNF and IFN synthesis
Apoptosis in lymphocytes (lymphocytopenia)
Neutrophilia
Antishock effect of GC
Decreased capillary membrane permeability –> enhances microcirculation
In high dosage: vasoconstriction
Neuroprotective effect of GC
Local vasoconstriction
Counteract lipidperoxidation and enhances microcirculation
Cortisol
GC
Relative potency: 1
Effect: Short
Prednisolone
GC
Relative potency: 4
Dosage: 0,5-1 mg/kg 24h
Effect: Medium
Methylprednisolone
GC
Relative potency: 5-7
Effect: Medium
Triamcinolone
GC
Relative potency: 5-10
Effect: Medium
Betamethasone
GC
Relative effect: 25-30
Effect: Long
Dexamethasone
GC
Relative effect: 25-30
Effect: Long
Beclomethason
GC
Relative potency: 300-400
Effect: Local
Fluticason
GC
Relative potency: 400-500
Effect: Local
Budesonide
GC
Effect: Oral
Active substances GC (9)
Cortisol Prednisolone Methylprednisolone Triamcinolone Betamethasone Dexamethasone Beclomethason Fluticason Budesonide
Side effects of GC (11)
- Hypothalamus-hypophysis-adrenal cortex axis inhibition (atrophy, addison’s disease)
- Gastric ulcers
- Hepatopathy (ALKP increases)
- Pancreatitis
- Glaucoma. cataracta
- Thinning of skin, delayed wound healing, alopecia
- Polyuria/Polydipsia
- Polyphagia
- Remobilizing fats (stomach or face)
- Muscle atrophy
- Immunosupression
Systemic use of GC
- High dosage once
- Alternate day therapy (prednisolone and Methylprednisolone)
- Long acting injections
Indication of GC
- Local usage (atopic dermatitis, otitis externa, mastitis)
- Single injectable dose
- Asthma, RAO –> inhalation usage
- Intraarticular
- ADT
- Depot injection
What does NSAIDs inhibit?
NSAIDs inhibit the production of COX (PGF, PGE, PGI, TX, prostaglandins and Thromboxins)
Mechanism of COX-1
Located in the stomach, kidney and platelets, present all the time to protect us
Kidney: Dilate vessels, increase renal blood flow
Platelets: Aid in coagulation
Stomach: Increase mucous production, decrease acid production and increase regeneration rate.
Inhibition therefore leads to vasoconstriction, no coagulation and gastric ulcers